These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes. Killackey SA; Sorbara MT; Girardin SE Front Cell Infect Microbiol; 2016; 6():38. PubMed ID: 27066460 [TBL] [Abstract][Full Text] [Related]
25. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection. Thanabalasuriar A; Kim J; Gruenheid S Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681 [TBL] [Abstract][Full Text] [Related]
26. Regulation of virulence: the rise and fall of gastrointestinal pathogens. Kitamoto S; Nagao-Kitamoto H; Kuffa P; Kamada N J Gastroenterol; 2016 Mar; 51(3):195-205. PubMed ID: 26553054 [TBL] [Abstract][Full Text] [Related]
27. Type III Secreted Virulence Factors Manipulating Signaling to Actin Dynamics. Stradal TE; Costa SC Curr Top Microbiol Immunol; 2017; 399():175-199. PubMed ID: 27744505 [TBL] [Abstract][Full Text] [Related]
28. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection. Serapio-Palacios A; Finlay BB Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947 [TBL] [Abstract][Full Text] [Related]
30. Bacterial adhesion and host cell factors leading to effector protein injection by type III secretion system. Bohn E; Sonnabend M; Klein K; Autenrieth IB Int J Med Microbiol; 2019 Jul; 309(5):344-350. PubMed ID: 31178419 [TBL] [Abstract][Full Text] [Related]
31. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Kobayashi T; Ogawa M; Sanada T; Mimuro H; Kim M; Ashida H; Akakura R; Yoshida M; Kawalec M; Reichhart JM; Mizushima T; Sasakawa C Cell Host Microbe; 2013 May; 13(5):570-583. PubMed ID: 23684308 [TBL] [Abstract][Full Text] [Related]
32. Linking Pathogen Virulence, Host Immunity and The Microbiota at the Intestinal Barrier. Nunez G Keio J Med; 2017; 66(1):14. PubMed ID: 28356548 [TBL] [Abstract][Full Text] [Related]
33. Xenophagy in innate immunity: A battle between host and pathogen. Wang Z; Li C Dev Comp Immunol; 2020 Aug; 109():103693. PubMed ID: 32243873 [TBL] [Abstract][Full Text] [Related]
34. Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Bliska JB; Wang X; Viboud GI; Brodsky IE Cell Microbiol; 2013 Oct; 15(10):1622-31. PubMed ID: 23834311 [TBL] [Abstract][Full Text] [Related]
35. Enteric Virome Sensing-Its Role in Intestinal Homeostasis and Immunity. Metzger RN; Krug AB; Eisenächer K Viruses; 2018 Mar; 10(4):. PubMed ID: 29570694 [TBL] [Abstract][Full Text] [Related]
36. Regulation of Salmonella-host cell interactions via the ubiquitin system. Herhaus L; Dikic I Int J Med Microbiol; 2018 Jan; 308(1):176-184. PubMed ID: 29126744 [TBL] [Abstract][Full Text] [Related]
37. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD). Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194 [TBL] [Abstract][Full Text] [Related]
38. Interaction of Yersinia with the gut: mechanisms of pathogenesis and immune evasion. Dube P Curr Top Microbiol Immunol; 2009; 337():61-91. PubMed ID: 19812980 [TBL] [Abstract][Full Text] [Related]
40. The Tip of the Iceberg: On the Roles of Regulatory Small RNAs in the Virulence of Enterohemorrhagic and Enteropathogenic Bhatt S; Egan M; Jenkins V; Muche S; El-Fenej J Front Cell Infect Microbiol; 2016; 6():105. PubMed ID: 27709103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]